دورية أكاديمية
Evaluation of in-stent restenosis in the APPROACH trial (assessment on the prevention of progression by Rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history)
| العنوان: | Evaluation of in-stent restenosis in the APPROACH trial (assessment on the prevention of progression by Rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history) |
|---|---|
| المؤلفون: | Garcia-Garcia, H.M. (Hector), Garg, S.A. (Scot), Brugaletta, S. (Salvatore), Morocutti, G. (Giorgio), Ratner, R.E. (Robert), Kolatkar, N.S. (Nikheel), Kravitz, B.G. (Barbara), Miller, D.M. (Diane), Huang, C. (Chunmei), Nesto, R.W. (Richard), Serruys, P.W.J.C. (Patrick), Aftring, R.P. (R.), Wolstenholme, J. (Jane), Saarinen, J. (Jari), Fowler, R. (R.), Hoffman, J. (Jonathan), Steele-Norwood, D. (D.), Russell, R. (Robert), Young, S. (S.), Chou, Y.F., McMorn, S. (Steve), Kirsch, C. (Courtney), Louridas, B. (Bonnie), Olivieria, T. (Teresa), Mattioli, D. (Debra), Miller, D. (D.), Nguyen, C. (C.), Jahnke, K. (Kristoph), Mintz, G.S. (Gary), Lachin, J. (J.), Abrahamson, M. (M.), Carson, P. (P.), Jones, P. (Peter) |
| المصدر: | International Journal of Cardiovascular Imaging vol. 28 no. 3, pp. 455-465 |
| سنة النشر: | 2012 |
| المجموعة: | RePub - Publications from Erasmus University, Rotterdam |
| مصطلحات موضوعية: | Atherosclerosis, IVUS, Restenosis, Type 2 diabetes |
| الوصف: | To determine (1) the medium-term effect of rosiglitazone and glipizide on intra-stent neointima hyperplasia, (2) restenosis pattern as assessed by intravascular ultrasound (IVUS) and quantitative coronary angiography (QCA) in patients with T2DM and coronary artery disease. A total of 462 patients with T2DM were randomized to rosiglitazone or glipizide for up to 18 months in the APPROACH trial, and had evaluable baseline and follow-up IVUS examinations. There was no significant difference in the size of plaque behind stent between the rosiglitazone and glipizide groups at 18 months among those treated with a bare metal stent (-5.6 mm 3 vs. 1.9 mm 3; P = 0.61) or with a drug-eluting stent (12.1mm 3 vs. 5.5 mm 3; P = 0.09). Similarly, there was no significant difference in pe |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| العلاقة: | http://repub.eur.nl/pub/62843Test; urn:hdl:1765/62843 |
| DOI: | 10.1007/s10554-011-9836-z |
| الإتاحة: | https://doi.org/10.1007/s10554-011-9836-zTest http://repub.eur.nl/pub/62843Test |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.E7D2B5B6 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1007/s10554-011-9836-z |
|---|